2011
DOI: 10.1055/s-0031-1272965
|View full text |Cite
|
Sign up to set email alerts
|

Marinobufagenin Levels in Preeclamptic Patients: A Preliminary Report

Abstract: Preeclampsia is a disorder resulting in significant fetomaternal complications with no definitive pharmacological intervention. A bufadienolide, marinobufagenin, has been implicated in the etiology of preeclampsia. We investigated both the blood and urine levels of marinobufagenin in preeclamptic and control subjects. Preeclamptic and normotensive pregnant women were recruited at various gestational age periods. Blood and urine specimens were obtained and analyzed for marinobufagenin levels and creatinine. The… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
17
0

Year Published

2012
2012
2021
2021

Publication Types

Select...
10

Relationship

3
7

Authors

Journals

citations
Cited by 27 publications
(17 citation statements)
references
References 23 publications
0
17
0
Order By: Relevance
“…Those studies using more specific immunoassays disagreed on whether EO either was (48) or was not (34) increased in pregnancy. Other work has also implicated marinobufagenin (MBG), a bufodienolide, in the clinical pathogenesis of PE (1,34) and elevated levels of MBG and digoxin-like materials have been described in pregnancy and become superelevated in PE (20,34,43). We did not measure marinobufagenin or digoxin in this study; however, our radioreceptor assay of the nonpolar SPE samples (which would include digoxin and marinobufagenin) suggests that these materials in rat plasma during normal pregnancy are collectively much less biologically active in our RRA system compared with their polar SPE ("ouabain-like") counterparts.…”
Section: Discussionmentioning
confidence: 99%
“…Those studies using more specific immunoassays disagreed on whether EO either was (48) or was not (34) increased in pregnancy. Other work has also implicated marinobufagenin (MBG), a bufodienolide, in the clinical pathogenesis of PE (1,34) and elevated levels of MBG and digoxin-like materials have been described in pregnancy and become superelevated in PE (20,34,43). We did not measure marinobufagenin or digoxin in this study; however, our radioreceptor assay of the nonpolar SPE samples (which would include digoxin and marinobufagenin) suggests that these materials in rat plasma during normal pregnancy are collectively much less biologically active in our RRA system compared with their polar SPE ("ouabain-like") counterparts.…”
Section: Discussionmentioning
confidence: 99%
“…MBG, but not EO, is markedly elevated in PE [22]. Puschett and co-workers developed an ELISA with high specificity for MBG [23], which revealed a five-fold increase in serum MBG and a four-fold increase in urine MBG levels in preeclamptic patients versus normotensive pregnant women [24]. Plasma levels of MBG, but not EO, become elevated in patients with moderate PE [25].…”
Section: Introductionmentioning
confidence: 99%
“…Solving for pressure, the formula becomes: P=Q x R. Evidence that excessive volume expansion is an important causative mechanism in PE has been provided by experiments performed by Chesley and his associates [8,9]. These workers determined that PE patients infused with saline demonstrated reduced excretion of sodium in the urine compared with both normal pregnant patients and those with pregnancy-related hypertension ( Figure 3) [10]. The relationship between the filtered load of sodium and its renal clearance.…”
Section: Other Hypertensive Statesmentioning
confidence: 99%